These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 31761964)

  • 1. Genetic instrumental variable analysis: time to call mendelian randomization what it is. The example of alcohol and cardiovascular disease.
    Mukamal KJ; Stampfer MJ; Rimm EB
    Eur J Epidemiol; 2020 Feb; 35(2):93-97. PubMed ID: 31761964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.
    Bowden J; Davey Smith G; Burgess S
    Int J Epidemiol; 2015 Apr; 44(2):512-25. PubMed ID: 26050253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mendel's laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues.
    Davey Smith G; Holmes MV; Davies NM; Ebrahim S
    Eur J Epidemiol; 2020 Feb; 35(2):99-111. PubMed ID: 32207040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian Randomization.
    Grover S; Del Greco M F; Stein CM; Ziegler A
    Methods Mol Biol; 2017; 1666():581-628. PubMed ID: 28980266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates.
    Taylor AE; Davies NM; Ware JJ; VanderWeele T; Smith GD; Munafò MR
    Econ Hum Biol; 2014 Mar; 13(100):99-106. PubMed ID: 24388127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits.
    Silverwood RJ; Holmes MV; Dale CE; Lawlor DA; Whittaker JC; Smith GD; Leon DA; Palmer T; Keating BJ; Zuccolo L; Casas JP; Dudbridge F;
    Int J Epidemiol; 2014 Dec; 43(6):1781-90. PubMed ID: 25192829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constrained instruments and their application to Mendelian randomization with pleiotropy.
    Jiang L; Oualkacha K; Didelez V; Ciampi A; Rosa-Neto P; Benedet AL; Mathotaarachchi S; Richards JB; Greenwood CMT;
    Genet Epidemiol; 2019 Jun; 43(4):373-401. PubMed ID: 30635941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending Causality Tests with Genetic Instruments: An Integration of Mendelian Randomization with the Classical Twin Design.
    Minică CC; Dolan CV; Boomsma DI; de Geus E; Neale MC
    Behav Genet; 2018 Jul; 48(4):337-349. PubMed ID: 29882082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian randomisation for mediation analysis: current methods and challenges for implementation.
    Carter AR; Sanderson E; Hammerton G; Richmond RC; Davey Smith G; Heron J; Taylor AE; Davies NM; Howe LD
    Eur J Epidemiol; 2021 May; 36(5):465-478. PubMed ID: 33961203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Mendelian randomization': an approach for exploring causal relations in epidemiology.
    Gupta V; Walia GK; Sachdeva MP
    Public Health; 2017 Apr; 145():113-119. PubMed ID: 28359378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak and pleiotropy robust sex-stratified Mendelian randomization in the one sample and two sample settings.
    Karageorgiou V; Tyrrell J; Mckinley TJ; Bowden J
    Genet Epidemiol; 2023 Mar; 47(2):135-151. PubMed ID: 36682072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRBEE: A bias-corrected multivariable Mendelian randomization method.
    Lorincz-Comi N; Yang Y; Li G; Zhu X
    HGG Adv; 2024 Jul; 5(3):100290. PubMed ID: 38582968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.
    Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR
    Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.
    Burgess S; Thompson SG
    Am J Epidemiol; 2015 Feb; 181(4):251-60. PubMed ID: 25632051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of instrumental variable estimators for Mendelian randomization.
    Burgess S; Small DS; Thompson SG
    Stat Methods Med Res; 2017 Oct; 26(5):2333-2355. PubMed ID: 26282889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mendelian Randomization as an Approach to Assess Causality Using Observational Data.
    Sekula P; Del Greco M F; Pattaro C; Köttgen A
    J Am Soc Nephrol; 2016 Nov; 27(11):3253-3265. PubMed ID: 27486138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting findings from Mendelian randomization using the MR-Egger method.
    Burgess S; Thompson SG
    Eur J Epidemiol; 2017 May; 32(5):377-389. PubMed ID: 28527048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the instrumental inequalities in simulated mendelian randomization analyses with coarsened exposures.
    Diemer EW; Shi J; Hernan MA; Swanson SA
    Eur J Epidemiol; 2024 May; 39(5):491-499. PubMed ID: 38819552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mendelian randomization for cardiovascular diseases: principles and applications.
    Larsson SC; Butterworth AS; Burgess S
    Eur Heart J; 2023 Dec; 44(47):4913-4924. PubMed ID: 37935836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing concordance of instrumental variable effects in generalized linear models with application to Mendelian randomization.
    Dai JY; Chan KC; Hsu L
    Stat Med; 2014 Oct; 33(23):3986-4007. PubMed ID: 24863158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.